title: Guanfacine treatment of Alzheimer's disease.
authors.affiliation: Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland.
authors.forename: J
authors.initials: J
authors.lastname: Schlegel
authors.forename: E
authors.initials: E
authors.lastname: Mohr
authors.forename: J
authors.initials: J
authors.lastname: Williams
authors.forename: U
authors.initials: U
authors.lastname: Mann
authors.forename: M
authors.initials: M
authors.lastname: Gearing
authors.forename: T N
authors.initials: TN
authors.lastname: Chase
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D016316:Guanfacine; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D010648:Phenylacetates / Q000494:pharmacology*; D011897:Random Allocation
chemical_list: D000316:Adrenergic alpha-Agonists; D006146:Guanidines; D010648:Phenylacetates; D016316:Guanfacine